Retrospective longitudinal study of patients and prescriber characteristics associated with new DOAC prescriptions in a CCG without restrictions to DOAC use
Publication date
2018End of embargo
2019-03-23Metadata
View full catalogue recordKeywords
Direct oral anticoagulants (DOACs); Warfarin; Prescriptions; Patient characteristics; Prescriber characteristics; Clinical Commissioning Group (CCG)Permissions
© 2018 Wiley. This is the peer reviewed version of the conference abstract above, which has been published in final form at https://doi.org/10.1111/ijpp.12442. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.Peer-Reviewed
yesAbstract
Direct oral anticoagulants (DOACs) uptake for stroke prevention in atrial fibrillation has been slow.[1] This study aimed to profile the prescribing of DOACs over three years to identify factors associated with DOAC prescribing in a Clinical Commissioning Group (CCG) without restrictions to DOACs use. The objectives were to identify:
- Characteristics of patients prescribed oral anticoagulant (OAC) in a sample of general practices;
- Who initiated the prescribing of OAC;
- Recorded reasons for prescribing a DOAC rather than warfarin;